期刊文献+

多普勒超声心动图筛查门肺高压症的临床研究

Clinical study on the value of Doppler echocardiography in screening portopulmonary hypertension
下载PDF
导出
摘要 目的:调查门肺高压症在国内的发病情况,评估二维多普勒超声心动图作为筛查方法的临床效果。方法:于77例接受手术治疗的肝硬化门静脉高压症病人,行术前二维多普勒超声心动图检查,测算肺动脉收缩压和肺加速时间以筛查门肺高压症病人;并和标准诊断法右心导管法结果进行比较。结果:本研究样本人群中的门肺高压症发病率为3.9%,二维多普勒超声心动图筛查试验的灵敏度为100%,特异度为87.8%,真实度88.3%,阳性预测值为25%,阴性预测值为100%。结论:国内的门肺高压症发病情况与国际上报道的相似。二维多普勒超声心动图筛查法的灵敏度和阴性预测值高;阴性结果有助于排除门肺高压症,而阳性结果必须经右心导管法确诊。 Objective To investigate the incidence of portopulmonary hypertension, and to evaluate the value of Doppler eehocardiography in screening for portopuhnonary hypertension in patients with portal hypertension. Methods Seventy seven patients with liver cirrhosis were studied by Doppler Eehoeardiography preoperatively; systolic puhnonary arterial pressure and puhnonary acceleration time were estimated in sereening portopuhnonary hypertension, subsequently, right heart pressure was measured by cardiac cathetherization before induction of anesthesia. The results obtained by these 2 methods were compared. Results The ineidence of portopulmonary, hypertension in the patients with portal hypertension studied was 3.9%. The sensitivity, specificity, aceuracv rate, positive predictive value and negative predictive value of Doppler echoeardiography in screening for portopulmonary hypertension were 100%, 87.8%, 88.3%, 25% and 100%, respeetively. Conclusions The incidence of portopuhnonary hypertension obtained in this study is similar to those from the literature. As a screening test, Doppler echocardiography offers very high sensitivity and negative predictive value. Negative results can be used directly to exclude portopulmonary hypertension, while positive results should be checked by cardiac cathetherization.
出处 《外科理论与实践》 2005年第5期441-444,共4页 Journal of Surgery Concepts & Practice
关键词 高血压 肺性 高血压 门静脉 超声心动描记术 多普勒 患病率 Portopuhnonary hypertension Portal hypertension Doppler eehoeardiography Incidence
  • 相关文献

参考文献10

  • 1花荣,曹晖,吴志勇.门肺高压症的诊治进展[J].外科理论与实践,2004,9(2):162-164. 被引量:3
  • 2Krowka M J, Plevak DJ, FindlayJY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with porto pulmonary hypertension undergoing liver transplantation[J]. Liver Transpl, 2000,6(4):443-450.
  • 3刘汉英 李建蓉.超声诊断[A].见:翁心植主编.慢性阻塞性肺疾病与肺原性心脏病[M].北京:北京出版社,1999.136-139.
  • 4Budhiraja R, Hassoun PM. Porto- pulmonary hypertension: a tale of two circulations[J]. Chest, 2003,123(2):562-576.
  • 5Hoeper MM, Krowka M J, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome[J]. Lancet,2004,363 (9419): 1461-1468.
  • 6Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation[J]. Circulation, 1984,70(4):657-662.
  • 7Torregrosa M, Genesca J, Gonzalez A, et al. Role of doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates [J]. Transplantation, 2001,71(4):572-574.
  • 8Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study[J]. Hepatology, 2003,37(2):401-409.
  • 9Newman JH. Treatment of primary pulmonary hypertension - the next generation[J]. N Engl J Med, 2002,346(12):933-935.
  • 10Kuo PC, Plotkin JS, Gaine S, et al. Portopulmonary hypertension and the liver transplant candidate [J]. Transplantation, 1999, 67(8):1087-1093.

二级参考文献24

  • 1[1]McDonnell PJ, Toye PA,Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? [J]. Am Rev Respir Dis, 1983,127(4):437-441.
  • 2[2]Hadengue A, Benhayoun MK, Lebrec D,et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics [J]. Gastroen terology, 1991, 100(2):520-528.
  • 3[3]Yang YY,Lin HC, Lee WC,et al. Portopulmonary hypertension: distinctive hemodynamic and clinical manifesta tions[J]. J Gastroenterol, 2001,36 (3):181-186.
  • 4[4]Budhiraja R, Hassoun PM. Porto- pulmonary hypertension: a tale of two circulations[J].Chest, 2003, 123 (2): 562-576.
  • 5[5]Christman BW, McPherson CD, Newman JH,et al. An im balance between the excretion of thromboxane and prostacyelin metabolites in pulmonary hypertension[J]. N Engl J Med, 1992, 327 (2):70-75.
  • 6[6]Tuder RM, Cool CD, Geraci MW,et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension[J]. Am J Respir Crit Care Med, 1999, 159 (6): 1925-1932.
  • 7[7]Chang H, Wu GJ, Wang SM,et al. Plasma endothelin levels and surgically correctable pulmonary hypertension [J]. Ann Thorac Surg, 1993,55(2):450-458.
  • 8[8]Cella G, Bellotto F, Tona F,et al. Plasma markers of en dothelial dysfunction in pulmonary hypertension[J]. Chest, 2001,120 (4):1226-1230.
  • 9[9]Morse JH, Jones AC, Barst RJ, et al. Mapping of familial primary pulmonary hypertension locus(PPH1) to chromo some 2q31-q32[J]. Circulation, 1997, 95 (12): 2603-2606.
  • 10[10]Eddahibi S, Humbert M, Fadel E, et al. Serotonin trans porter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hyper tension[J]. J Clin Invest, 2001, 108(8): 1141-1150.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部